Zevra Therapeutics ZVRA Earnings Call Transcripts

NASDAQ ZVRA
$11.85 -0.07 (-0.59%)
At close: Nov 11, 2026 · 4:00 PM EST
3 earnings calls on file for Zevra Therapeutics, from Q3 2025 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Zevra Therapeutics Q3 2026 Earnings Call

Nov 3, 2026 6,123 words · 27 min read
  • Nichol OchsnerVice President of Investor Relations and Corporate Communications
  • Neil McFarlanePresident and Chief Executive Officer
  • Joshua SchaferChief Commercial Officer
  • Justin RenzChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Zevra Therapeutics Earnings Call Transcripts

Calls3
LatestNov 3, 2026
SinceQ3 2025

Fiscal 2026

Fiscal 2025

All 3 Zevra Therapeutics transcripts Register to get access to Zevra Therapeutics’s earnings call transcripts.